Shandong Weifang Rainbow Chemical Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Weifang Rainbow Chemical has a total shareholder equity of CN¥6.9B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 48.3%. Its total assets and total liabilities are CN¥16.0B and CN¥9.2B respectively. Shandong Weifang Rainbow Chemical's EBIT is CN¥1.1B making its interest coverage ratio 58.1. It has cash and short-term investments of CN¥3.9B.
Key information
48.3%
Debt to equity ratio
CN¥3.32b
Debt
| Interest coverage ratio | 58.1x |
| Cash | CN¥3.91b |
| Equity | CN¥6.86b |
| Total liabilities | CN¥9.15b |
| Total assets | CN¥16.02b |
Recent financial health updates
Recent updates
We Think That There Are More Issues For Shandong Weifang Rainbow Chemical (SZSE:301035) Than Just Sluggish Earnings
Nov 04
Returns On Capital At Shandong Weifang Rainbow Chemical (SZSE:301035) Have Stalled
Oct 24The Market Lifts Shandong Weifang Rainbow Chemical Co., Ltd (SZSE:301035) Shares 28% But It Can Do More
Sep 27Take Care Before Diving Into The Deep End On Shandong Weifang Rainbow Chemical Co., Ltd (SZSE:301035)
Aug 07Shandong Weifang Rainbow Chemical (SZSE:301035) Has A Somewhat Strained Balance Sheet
Jul 12Shandong Weifang Rainbow Chemical (SZSE:301035) Has More To Do To Multiply In Value Going Forward
Jun 21Why Shandong Weifang Rainbow Chemical's (SZSE:301035) Shaky Earnings Are Just The Beginning Of Its Problems
May 02Shandong Weifang Rainbow Chemical Co., Ltd's (SZSE:301035) Shares Not Telling The Full Story
Apr 04Financial Position Analysis
Short Term Liabilities: 301035's short term assets (CN¥12.6B) exceed its short term liabilities (CN¥8.7B).
Long Term Liabilities: 301035's short term assets (CN¥12.6B) exceed its long term liabilities (CN¥420.8M).
Debt to Equity History and Analysis
Debt Level: 301035 has more cash than its total debt.
Reducing Debt: 301035's debt to equity ratio has increased from 8.8% to 48.3% over the past 5 years.
Debt Coverage: 301035's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 301035's interest payments on its debt are well covered by EBIT (58.1x coverage).